DYSF and neuromuscular disease caused by qualitative or quantitative defects of dysferlin: Subsequently, we examined the correlation between the expression of key proteins and the clinical characteristics of the patients to identify pathogenic targets associated with DYSF mutations in dysferlinopathy.